SEC Company Response from LEMAITRE VASCULAR INC (LMAT) (CIK 0001158895) (LMAT) — May 28, 2020
LEMAITRE VASCULAR INC (LMAT) (CIK 0001158895)
Date: May 28, 2020 · CIK: 0001158895 · Accession: 0001437749-20-011935
AI Filing Summary & Sentiment
File numbers found in text: 333-238541
Letter
lmat20200527_corresp.htm
May 28, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Christine Westbrook
Re:
LeMaitre Vascular, Inc. (the “Company”)
Registration Statement on Form S-3
Filed: May 20, 2020
File No. 333-238541
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement to become effective at 4:30 p.m. Eastern Time on June 1, 2020 or as soon thereafter as is practicable, or at such later time as the Company may orally request via telephone call to the staff. The Company hereby authorizes each of Nicole Brookshire and Miguel Vega of Cooley LLP to make such request on its behalf.
Once the above-referenced Registration Statement has been declared effective, please orally confirm that event with Miguel Vega of Cooley LLP at (617) 937-2319, or in his absence, Nicole Brookshire of Cooley LLP at (212) 479-6157.
Very truly yours,
LeMaitre Vascular, Inc.
Show Raw Text
CORRESP 1 filename1.htm lmat20200527_corresp.htm May 28, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Christine Westbrook Re: LeMaitre Vascular, Inc. (the “Company”) Registration Statement on Form S-3 Filed: May 20, 2020 File No. 333-238541 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement to become effective at 4:30 p.m. Eastern Time on June 1, 2020 or as soon thereafter as is practicable, or at such later time as the Company may orally request via telephone call to the staff. The Company hereby authorizes each of Nicole Brookshire and Miguel Vega of Cooley LLP to make such request on its behalf. Once the above-referenced Registration Statement has been declared effective, please orally confirm that event with Miguel Vega of Cooley LLP at (617) 937-2319, or in his absence, Nicole Brookshire of Cooley LLP at (212) 479-6157. Very truly yours, LeMaitre Vascular, Inc. By: /s/ Laurie Churchill Laurie Churchill, Esq. Senior Vice President and General Counsel